CD274 and hepatocellular carcinoma: AMPNs2-treatedcells also revealed less invasive ability than ANs2-treated cells,as determined by the number of cells that migrated through a matrigelmatrix after 24 h (51.4 ± 8.6 versus 21.2 ± 4.7) in thesecultures (Figure 5H).These findings indicated that in Hepa1-6 cells treated with equaldoses of ANs and AMPNs, AMPNs had superior performance to inhibitPin1 and increase PD-L1 expression, and attenuate cell migration,proliferation, and invasion, suggesting their increased potentialutility to enhance ICI therapy for HCC.